# Clarifying Optimal Sodium Intake Project

Study · id `cardio:ct-nct02738736` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02738736](<https://clinicaltrials.gov/study/NCT02738736>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02738736

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

## Technical summary

Registry record NCT02738736. Randomized; no masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2020-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 269 participants (enrolled count; ClinicalTrials.gov record NCT02738736, source copy `cardio:ctgov-nct02738736-2021-04-28`, retrieved 2026-10-26)
- Start date: 2016-04 (registry gives no type) (ClinicalTrials.gov record NCT02738736, source copy `cardio:ctgov-nct02738736-2021-04-28`, retrieved 2026-10-26)
- Primary completion: 2020-08 (actual) (ClinicalTrials.gov record NCT02738736, source copy `cardio:ctgov-nct02738736-2021-04-28`, retrieved 2026-10-26)
- Completion: 2020-08 (actual) (ClinicalTrials.gov record NCT02738736, source copy `cardio:ctgov-nct02738736-2021-04-28`, retrieved 2026-10-26)
- Countries: Ireland (ClinicalTrials.gov record NCT02738736, source copy `cardio:ctgov-nct02738736-2021-04-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02738736-2021-04-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clarifying Optimal Sodium Intake Project
- Acronym: COSIP-1
- Condition: Blood Pressure
- Condition: Hypertension
- Condition: Kidney Disease
- Condition: Cardiovascular Disease
- Intervention (Behavioral): Sodium Reduction
- Lead sponsor: University College Hospital Galway
- Lead sponsor class: OTHER
- Collaborator: European Research Council
- Collaborator class: OTHER
- Collaborator: National University of Ireland, Galway, Ireland
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University College Hospital Galway (`cardio:org-university-college-hospital-galway`)
- Registry lists this organization as a collaborator: National University of Ireland, Galway, Ireland (`cardio:org-national-university-of-ireland-galway-ireland`)

## Provenance

Content hash: e56b8eb80f4519bad45036b1dc981d5adfe61fb31b62748983905de974adc255
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
